<DOC>
	<DOCNO>NCT00001894</DOCNO>
	<brief_summary>This study compare two treatment : pacemaker implantation percutaneous transluminal septal ablation ( PTSA ) patient hypertrophic cardiomyopathy ( HCM ) , condition heart muscle thicken obstructs flow blood heart . The reduced blood flow cause chest pain , shortness breath , palpitation , tiredness , lightheadedness fainting . Patients HCM help drug therapy may participate study . The standard treatment patient septal myectomy , operation surgeon shave muscle obstruct blood flow . Another treatment option implantation type pacemaker cause heart contract certain way reduces blood flow obstruction improve symptom . The pacemaker implant local anesthesia usually take less hour . PTSA experimental treatment may provide third option . In PTSA , thin tube ( catheter ) insert blood vessel feed heart muscle cause blood flow obstruction . A small amount alcohol inject catheter destroy muscle relieve obstruction . Candidates follow screen test : chest X-ray , electrocardiogram , echocardiogram , exercise test , exercise radionuclide angiography , exercise thallium scintigraphy , Holter monitoring , cardiac catheterization , electrophysiology study , coronary angiography . Participants assign one two treatment group : pacemaker implantation PTSA . Patients PTSA group also magnetic resonance imaging scan start study , 3 7 day PTSA , end study , order observe change heart 's shape . All patient fill questionnaire answering question quality life . Patients ' progress follow monthly phone call . In addition , various test , exercise test echocardiography , do repeat visit three six month measure treatment result . Patients complete quality-of-life questionnaire visit .</brief_summary>
	<brief_title>A Comparison Two Treatments : Pacemaker Percutaneous Transluminal Septal Ablation Hypertrophic Cardiomyopathy</brief_title>
	<detailed_description>Patients obstructive HCM drug-refractory symptom refer leave ventricular myotomy myectomy ( LVMM ) mitral valve replacement . As alternative therapy cardiac surgery , propose compare ability dual chamber ( DDD ) pace percutaneous transluminal septal ablation ( PTSA ) reduce leave ventricular ( LV ) outflow pressure gradient improve exercise performance patient obstructive HCM severe symptom fail benefit pharmacotherapy .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>Patients either gender , age 1880 year . NYHA functional class III/IV , syncope , great equal 2 presyncope despite verapamil and/or Betablocker therapy . LV outflow tract gradient great equal 30 mm Hg rest great equal 50 mm Hg follow isoproterenol infusion heart rate great 100 bpm . No patient midcavity obstructive HCM . No patient LV septal wall thickness le 15 mm estimate echocardiography . No patient great 50 percent luminal narrowing major coronary artery vessel . No patient chronic atrial fibrillation . No patient positive pregnancy test .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2002</verification_date>
	<keyword>HCM</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Septal Ablation</keyword>
	<keyword>Pacemaker</keyword>
</DOC>